Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Ashur-Fabian O, Blumenthal DT, Bakon M, Nass D, Davis PJ, Hercbergs A. Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature. Anticancer Drugs. 2013;24(3):315–23.
2. Nair AG, Pathak RS, Iyer VR, Gandhi RA. Optic nerve glioma: an update. Int Ophthalmol. 2014;34(4):999–1005.
3. Alireza M, Amelot A, Chauvet D, Terrier LM, Lot G, Bekaert O. Poor prognosis and challenging treatment of optic nerve malignant gliomas: Literature review and case report series. World Neurosurg. 2017;97:751.e1-751.e6.
4. Shapey J, Danesh-Meyer HV, Kaye AH. Diagnosis and management of optic nerve glioma. J Clin Neurosci. 2011;18(12):1585–91.
5. Minniti G, Quail T, Barnett GL, Osuolale EA, Deshmukh S, Hegde S, et al. Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study: a secondary analysis. Neuro Oncol. 2023;25(1):142–51.